NCT00871364View on ClinicalTrials.gov

A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Healthy
Interventions
DRUG

VENLAFAXINE TABLETS 50 mg , single dose

A: Experimental Subjects received EMCURE PHARMACEUTICALS LTD. formulated products under fed conditions

DRUG

Effexor® Tablets equivalent to 50 mg venlafaxine

B: Active comparator Subjects received Wyeth Pharmaceuticals Inc. formulated products under fed conditions

Trial Locations (1)

H4R 2N6

MDS Pharma Services, Saint-Laurent, Montreal

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00871364 - A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter